GH Research PLC - Ordinary shares, nominal value $0.025 per share (GHRS)

Historical Holders from Q2 2021 to Q3 2025

Symbol
GHRS on Nasdaq
Type / Class
Equity / Ordinary shares, nominal value $0.025 per share
Shares outstanding
61.5M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
44.5M
Holdings value
$618M
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
47
Number of buys
32
Number of sells
-14
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GH Research PLC - Ordinary shares, nominal value $0.025 per share (GHRS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOTECHNOLOGY VALUE FUND L P 14.2% $84.1M 8.83M BVF PARTNERS L P/IL 31 Mar 2025
Lynx1 Capital Management LP 13.9% +37% $123M $32.1M 8.6M +35.4% LYNX1 CAPITAL MANAGEMENT LP 30 Sep 2025
RA CAPITAL MANAGEMENT, L.P. 12.4% +10.9% $123M $11.7M 7.68M +10.5% RA Capital Management, L.P. 30 Jun 2025
RTW INVESTMENTS, LP 8.9% $52.4M 5.5M RTW Investments, LP 31 Mar 2025
FMR LLC 8.2% +18.6% $81.7M $13.5M 5.09M +19.8% FMR LLC 30 Jun 2025
Terwey Theis H 2.9% -58.8% $25.5M -$41.6M 1.78M -62% Terwey Theis H 30 Sep 2025

Institutional Holders of GH Research PLC - Ordinary shares, nominal value $0.025 per share (GHRS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 44.5M $618M +$14.4M $14.30 47
2025 Q2 43.6M $531M +$12.4M $12.19 37
2025 Q1 42.6M $470M +$133M $11.03 35
2024 Q4 30.7M $215M +$703K $7.00 31
2024 Q3 30.5M $204M +$470K $6.69 28
2024 Q2 30.4M $355M +$9.91M $11.66 28
2024 Q1 29.6M $316M +$9.7M $10.66 32
2023 Q4 29.6M $172M +$1.76M $5.80 35
2023 Q3 29M $291M -$8.21M $10.05 29
2023 Q2 29.6M $352M -$694K $11.87 34
2023 Q1 29.7M $237M -$9.78M $7.99 29
2022 Q4 30.9M $299M -$7.76M $9.72 32
2022 Q3 31.6M $367M -$9.45M $11.62 33
2022 Q2 32.6M $325M +$3.74M $9.98 33
2022 Q1 32.1M $587M +$37.2M $18.29 30
2021 Q4 30M $701M +$27M $23.33 29
2021 Q3 28.5M $625M +$21.3M $22.06 29
2021 Q2 27.6M $594M +$594M $21.73 34